Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,609 | 531 | 97.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.41 | 14 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $927.45 | 67 | $0 (2024) |
| UCB, Inc. | $695.48 | 45 | $0 (2024) |
| DAVOL INC. | $628.56 | 6 | $0 (2018) |
| Amgen Inc. | $582.17 | 37 | $0 (2023) |
| Allergan, Inc. | $578.21 | 49 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $563.65 | 33 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $471.41 | 33 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $436.27 | 45 | $0 (2024) |
| Lilly USA, LLC | $426.39 | 25 | $0 (2024) |
| Biogen, Inc. | $401.73 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,051 | 55 | ABBVIE INC. ($150.59) |
| 2023 | $1,423 | 84 | AbbVie Inc. ($406.98) |
| 2022 | $1,602 | 101 | ABBVIE INC. ($341.62) |
| 2021 | $1,008 | 70 | Amgen Inc. ($183.54) |
| 2020 | $653.27 | 58 | Sunovion Pharmaceuticals Inc. ($146.33) |
| 2019 | $1,137 | 81 | Teva Pharmaceuticals USA, Inc. ($165.60) |
| 2018 | $621.16 | 36 | DAVOL INC. ($147.54) |
| 2017 | $1,313 | 60 | Davol Inc. ($481.02) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Neurology | ||||||
| 08/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| 08/23/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.88 | General |
| 08/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Neurology | ||||||
| 08/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Neuroscience | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Neurology | ||||||
| 08/05/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROLOGY | ||||||
| 07/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 07/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Neuroscience | ||||||
| 07/17/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 07/15/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: EPILEPSY | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: PAIN | ||||||
| 06/24/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Neurology | ||||||
| 06/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Neurology | ||||||
| 06/18/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Neuroscience | ||||||
| 06/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 06/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Neuroscience | ||||||
| 06/03/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Immunology | ||||||
| 05/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Immunology | ||||||
| 05/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: General - DBS_NMD | ||||||
| 05/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Rare Disease | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 316 | 381 | $95,954 | $29,357 |
| 2022 | 9 | 307 | 387 | $86,646 | $29,517 |
| 2021 | 9 | 359 | 457 | $103,202 | $35,782 |
| 2020 | 9 | 351 | 448 | $94,217 | $29,969 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 74 | $16,798 | $5,830 | 34.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 45 | 78 | $14,820 | $5,420 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 86 | $12,986 | $4,841 | 37.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 29 | 31 | $15,624 | $4,468 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $13,920 | $4,270 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,975 | $2,065 | 29.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 16 | 16 | $5,056 | $1,464 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,246 | $537.29 | 43.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 11 | 11 | $8,529 | $461.01 | 5.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 51 | 98 | $18,620 | $7,060 | 37.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 36 | 41 | $20,664 | $5,871 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 86 | $12,986 | $5,031 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 43 | $9,761 | $3,664 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,396 | $3,044 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $5,850 | $1,936 | 33.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 13 | 13 | $4,108 | $1,322 | 32.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 21 | 22 | $2,502 | $912.75 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 31 | $2,759 | $677.39 | 24.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 62 | 119 | $22,610 | $8,939 | 39.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 48 | 53 | $26,712 | $8,503 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 112 | $16,912 | $5,587 | 33.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 53 | 53 | $11,925 | $4,122 | 34.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $10,788 | $3,369 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 20 | $4,540 | $1,672 | 36.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 39 | $3,471 | $1,467 | 42.3% |
About Dr. Melissa Klein, D.O
Dr. Melissa Klein, D.O is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821093675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Klein, D.O has received a total of $8,810 in payments from pharmaceutical and medical device companies, with $1,051 received in 2024. These payments were reported across 545 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($8,609).
As a Medicare-enrolled provider, Klein has provided services to 1,333 Medicare beneficiaries, totaling 1,673 services with total Medicare billing of $124,626. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Lexington, KY
- Active Since 06/17/2005
- Last Updated 01/22/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1821093675
Products in Payments
- BOTOX (Biological) $788.36
- Aimovig (Biological) $570.23
- Briviact (Drug) $561.99
- APTIOM (Drug) $416.71
- VYVGART (Drug) $375.48
- KESIMPTA (Drug) $351.71
- EMGALITY (Drug) $347.53
- UBRELVY (Drug) $345.24
- TYSABRI (Biological) $252.15
- DAV-XenMatrix AB (Device) $245.24
- QULIPTA (Drug) $235.91
- DAV-Phasix (Device) $235.78
- Hizentra (Biological) $199.08
- NURTEC ODT (Drug) $178.85
- INBRIJA (Drug) $161.54
- RYTARY (Drug) $153.45
- AJOVY (Drug) $149.36
- AJOVY (Biological) $146.80
- GILENYA (Drug) $139.55
- NUEDEXTA (Drug) $137.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615